Three World Financial Center
Phone: (212) 415-8593
Fax: (212) 303-2754
Dr. Brandon Schurter is an associate in the New York office of Locke Lord LLP. His practice focuses on intellectual property issues relating to biotechnology, pharmaceuticals, chemicals, molecular biology, and immunology.
During his doctoral work at UC San Diego, Dr. Schurter utilized biochemical, molecular biology, and cell biology techniques to elucidate the functional role of arginine methylation of NFAT Interacting Protein of 45kDa (NIP45) and RNA Helicase A (RHA). After graduation, he was awarded a European Molecular Biology Organization (EMBO) Long-Term Post-Doctoral Fellowship to study the role of arginine methylation in T-lymphocytes at the Pasteur Institute in Paris, France.
Dr. Schurter also worked at UC Irvine studying substrates specific to the co-activator associated arginine methyltransferase 1 (CARM1) prior to becoming a Scientific Advisor/Patent Agent with Morgan & Finnegan, LLP.
Formerly a scientific advisor with Locke Lord, Dr. Schurter has authored papers in several peer-reviewed journals and has presented his research at national and international conferences.
|Disclaimer & Trademark Notice
© 2014 Locke Lord LLP